The Biotech Growth Trust (BIOG) Share Price, News & Analysis

Company Overview

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

Key Stats

• Today's Range: 1,035.50 to 1,057.60
• 50-Day Range: 985.08 to 1,060
• 52-Week Range: 715 to 1,068.36
• Volume: 142,474 shs
• Average Volume: 66,478 shs
• Market Capitalization: £337.37 million
• P/E Ratio: 507.25
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIOG Stock Analysis - Frequently Asked Questions

How have BIOG shares performed this year?

The Biotech Growth Trust's stock was trading at GBX 894 at the beginning of 2024. Since then, BIOG stock has increased by 17.4% and is now trading at GBX 1,050.
View the best growth stocks for 2024 here.

How do I buy shares of The Biotech Growth Trust?

Shares of BIOG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of The Biotech Growth Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that The Biotech Growth Trust investors own include Polar Capital Technology Trust (PCT), Guild Esports (GILD), National Grid (NG.L), Solid Biosciences (SLDB), Scottish Mortgage (SMT), Touchstone Exploration (TXP) and Wheaton Precious Metals (WPM).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:BIOG
• CUSIP: N/A
• CIK: N/A
• Web: www.biotechgt.com
• Phone: +44-20-74264000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 2.07
• Trailing P/E Ratio: 507.25
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £74.60 million
• Net Margins: 92.85%
• Pretax Margin: N/A
• Return on Equity: 21.57%
• Return on Assets: 12.39%

Debt

• Debt-to-Equity Ratio: 13.03
• Current Ratio: 0.33
• Quick Ratio: 0.00

Sales & Book Value

• Annual Sales: £80.35 million
• Price / Sales: 4.20
• Cash Flow: GBX 11.97 per share
• Price / Cash Flow: 87.74
• Book Value: GBX 1,079 per share
• Price / Book: 0.97

Miscellaneous

• Outstanding Shares: 32,130,000
• Free Float: N/A
• Market Cap: £337.37 million
• Optionable: Not Optionable
• Beta: 0.50